3.06
price down icon0.65%   -0.02
after-market Handel nachbörslich: 3.04 -0.02 -0.65%
loading

Genelux Corp Aktie (GNLX) Neueste Nachrichten

pulisher
04:28 AM

Genelux Corp: A Promising Investment in the Oncolytic Virus Space with Key Clinical Milestones Ahead - TipRanks

04:28 AM
pulisher
Jul 15, 2025

What makes Genelux Corporation stock price move sharplyFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Genelux (NASDAQ:GNLX) Raised to “Hold” at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 08, 2025

Amgen Alum Takes Legal Reins of Biotech Firm Developing Cancer Treatment - Law.com

Jul 08, 2025
pulisher
Jul 07, 2025

Genelux Appoints Groen as General Counsel From Rani Therapeutics - Bloomberg Law News

Jul 07, 2025
pulisher
Jul 07, 2025

Biopharma Co. Genelux Hires Life Sciences Veteran As GC - Law360

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux appoints Eric Groen as general counsel, corporate secretary, CCO - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Former Amgen $10B Deal Architect Joins Genelux Leadership to Drive Strategic Growth - Stock Titan

Jul 07, 2025
pulisher
Jun 16, 2025

June 2025's Promising Penny Stocks For Savvy Investors - simplywall.st

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Sells 18,446 Shares of Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Lowers Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Millennium Management LLC Cuts Stake in Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Genelux Co. (NASDAQ:GNLX) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Wall Street Zen Downgrades Genelux (NASDAQ:GNLX) to Sell - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Genelux Co. (NASDAQ:GNLX) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Genelux (NASDAQ:GNLX) Trading Up 3.3% – Time to Buy? - Defense World

Jun 06, 2025
pulisher
Jun 02, 2025

Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jun 02, 2025
pulisher
May 14, 2025

Top Executives at Genelux Corp. Unload Thousands of Shares! - TipRanks

May 14, 2025
pulisher
May 13, 2025

GENELUX Corp Executives Sell Shares to Cover Taxes - TradingView

May 13, 2025
pulisher
May 10, 2025

Genelux Q3 EPS Raised by Brookline Capital Management - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Issues Optimistic Outlook for Genelux Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Genelux Corp.’s Promising Prospects: Buy Rating Backed by Strong Phase 3 Trial and Financial Position - TipRanks

May 09, 2025
pulisher
May 08, 2025

Genelux (GNLX) Price Target Lowered by Benchmark Analyst | GNLX Stock News - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Promising Developments in Genelux Corp.’s Olvi-Vec Drive Buy Rating - TipRanks

May 07, 2025
pulisher
May 07, 2025

H.C. Wainwright lifts Genelux stock target to $31, maintains buy By Investing.com - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

H.C. Wainwright lifts Genelux stock target to $31, maintains buy - Investing.com

May 07, 2025
pulisher
May 06, 2025

Genelux reports Q1 EPS (21c), consensus (24c) - TipRanks

May 06, 2025
pulisher
May 06, 2025

Genelux (GNLX) Shows Strong Progress in Cancer Treatment Trials | GNLX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Genelux Reports 71% Disease Control Rate in Lung Cancer Trial, Q1 2025 Earnings | GNLX Stock News - Stock Titan

May 06, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Has $716,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

May 02, 2025
pulisher
May 01, 2025

Genelux CEO Discusses Next-Gen Immuno-Oncology Pipeline and Key Milestones at Citizens Conference - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

LPL Financial LLC Has $222,000 Stock Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Apr 30, 2025
pulisher
Apr 18, 2025

Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 18, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Takes $41,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Apr 14, 2025
pulisher
Apr 08, 2025

Benchmark maintains $25 target on Genelux stock, optimistic on trials - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Benchmark maintains $25 target on Genelux stock, optimistic on trials By Investing.com - Investing.com India

Apr 08, 2025
pulisher
Apr 07, 2025

2seventy, TG, Springworks lead cancer index among Q1 market falls - BioWorld MedTech

Apr 07, 2025
pulisher
Apr 05, 2025

HC Wainwright Has Bearish Estimate for Genelux Q1 Earnings - The AM Reporter

Apr 05, 2025
pulisher
Apr 04, 2025

Guggenheim Sticks to Their Buy Rating for Genelux Corp. (GNLX) - The Globe and Mail

Apr 04, 2025
pulisher
Apr 04, 2025

Analysts Offer Predictions for Genelux Q1 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

What is HC Wainwright’s Forecast for Genelux Q1 Earnings? - Defense World

Apr 04, 2025
pulisher
Apr 01, 2025

Genelux (NASDAQ:GNLX) Given Buy Rating at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Genelux Corp. Buy Rating: Strategic Financial Positioning and Growth Prospects Amid Clinical Advancements - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

H.C. Wainwright maintains Buy on Genelux shares, target at $30 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

H.C. Wainwright maintains Buy on Genelux shares, target at $30 - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Genelux Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Mar 30, 2025
pulisher
Mar 29, 2025

Brokers Set Expectations for Genelux FY2024 Earnings - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

Research Analysts Set Expectations for Genelux Q1 Earnings - The AM Reporter

Mar 29, 2025
pulisher
Mar 28, 2025

Genelux reports FY24 EPS (95c), consensus (88c) - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Green Light: Genelux's Cancer Drug Olvi-Vec Advances as 2024 Data Shows 71% Disease Control - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

GENELUX Corp SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Down -29.7% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Genelux (GNLX) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Promising Clinical Trial Results and Strong Financial Position Justify Buy Rating for Genelux Corp. - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

What is HC Wainwright’s Estimate for Genelux Q1 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Benchmark maintains $25 target on Genelux following trial data - Investing.com

Mar 26, 2025
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
Kapitalisierung:     |  Volumen (24h):